- Page 5 and 6:
Comision Federal de la mejora regul
- Page 7 and 8:
Subject: MEXICO - Comments on PROY
- Page 9 and 10:
Item of PROY‐ NOM‐051 A.3.1 & A
- Page 11:
Annex 1.1: Ziesenitz, S.C.; 1996;
- Page 26 and 27:
Volume 61 Supplement 1 December 200
- Page 28 and 29:
Volume 61, Supplement 1, December 2
- Page 30 and 31:
S1 S5 S19 S40 S75 S100 S112 S122 S1
- Page 32 and 33:
FAO/WHO Scientific Update on carboh
- Page 34 and 35:
cardiovascular diseases and cancer)
- Page 36 and 37:
REVIEW Carbohydrate terminology and
- Page 38 and 39:
Table 2 Energy and macronutrient in
- Page 40 and 41:
are inulin and fructo oligosacchari
- Page 42 and 43:
Table 3 Principal physiological pro
- Page 44 and 45:
National Academy of Sciences in 200
- Page 46 and 47:
product contained X25% whole grain
- Page 48 and 49:
Henderson L, Gregory J, Swan G (200
- Page 50 and 51:
REVIEW Nutritional characterization
- Page 52 and 53:
Table 1 Nutritional characterizatio
- Page 54 and 55:
Table 2 Principles of carbohydrate
- Page 56 and 57:
Table 4 NSP in a selection of foods
- Page 58 and 59:
asked to consider both the ‘plant
- Page 60 and 61:
Table 5 Continued Plant-rich diet a
- Page 62 and 63:
account for any supplemented materi
- Page 64 and 65:
eaction vessels, with successive tr
- Page 66 and 67:
similar to the situation with sugar
- Page 68 and 69:
company working on dietary carbohyd
- Page 70 and 71:
van Dam RM, Seidell JC (2007). Carb
- Page 72 and 73:
2003). In establishing the energy v
- Page 74 and 75:
combustible energy of the fermentab
- Page 76 and 77:
glucose, starch, NSP) there is also
- Page 78 and 79:
generated through bioenergetic inef
- Page 80 and 81:
Table 4 cE, ME and NME, and content
- Page 82 and 83:
ME (Atwater general system) (Merill
- Page 84 and 85:
(o0.8 kg in the adult), increase af
- Page 86 and 87:
B1.4 MJ from protein in men, did no
- Page 88 and 89:
food and body weight, height or BMI
- Page 90 and 91:
esults may relate not only to the d
- Page 92 and 93:
ecologist, who is pre-occupied with
- Page 94 and 95:
Table 5 Effect of NSP (dietary fibr
- Page 96 and 97:
As already described, almost any ca
- Page 98 and 99:
in adolescents. Possible mechanisms
- Page 100 and 101:
unit, such as a grant or fellowship
- Page 102 and 103:
Conference on Medical Research. Ros
- Page 104 and 105:
Prentice AM, Poppitt SD (1996). Imp
- Page 106 and 107:
REVIEW Carbohydrate intake and obes
- Page 108 and 109:
Total carbohydrate intake Introduct
- Page 110 and 111:
composition of the diet did not sub
- Page 112 and 113:
European Journal of Clinical Nutrit
- Page 114 and 115:
postmenopausal US women (Howard et
- Page 116 and 117:
weight loss was greater after 6 mon
- Page 118 and 119:
European Journal of Clinical Nutrit
- Page 120 and 121:
its carbohydrate content, whereas a
- Page 122 and 123:
Table 4 Continued Duration Interven
- Page 124 and 125:
Despite a substantially lower GL fo
- Page 126 and 127:
increased physical activity has bee
- Page 128 and 129:
with normal glucose tolerance: the
- Page 130 and 131:
Westerterp KR, Verboeket-van de Ven
- Page 132 and 133: especially the NSP, complicates com
- Page 134 and 135: 1.21, 1.35, 1.40 and 1.64. The patt
- Page 136 and 137: esidual confounding provide the jus
- Page 138 and 139: carbohydrate have generated broadly
- Page 140 and 141: There is no good evidence of benefi
- Page 142 and 143: Meyer KA, Kushi LH, Jacobs Jr DR, S
- Page 144 and 145: from prospective studies which have
- Page 146 and 147: Table 3 Prospective studies of diet
- Page 148 and 149: of sucrose-containing foods, such a
- Page 150 and 151: Acrylamide Acrylamide is a chemical
- Page 152 and 153: Nicodemus KK, Jacobs Jr DR, Folsom
- Page 154 and 155: carbohydrate and fat may have a low
- Page 156 and 157: Foods having very different nutrien
- Page 158 and 159: esearch activities and food selecti
- Page 160 and 161: highest satiety score was boiled po
- Page 162 and 163: patients: a new basis for carbohydr
- Page 164 and 165: and lipid levels, to a greater exte
- Page 166 and 167: insufficient for the use of glycaem
- Page 168 and 169: Dr Hans Englyst: Director and share
- Page 175 and 176: Annex 1.4: US‐FDA GRAS Notificati
- Page 177 and 178: FDA/CFSAN/OFAS: Agency Response Let
- Page 179 and 180: Annex 1.5: US Health Claims Regulat
- Page 181: jlentini on PROD1PC65 with RULES 30
- Page 185 and 186: Isomaltulose is tooth friendly, unl
- Page 187 and 188: CONFIDENTIAL Regulatory Affairs & N
- Page 189 and 190: CONFIDENTIAL General or usual name:
- Page 191 and 192: CONFIDENTIAL Regulatory Affairs & N
- Page 193 and 194: CONFIDENTIAL Plasma glucose change
- Page 195 and 196: CONFIDENTIAL Regulatory Affairs & N
- Page 197 and 198: CONFIDENTIAL Rise in blood glucose
- Page 199 and 200: CONFIDENTIAL Regulatory Affairs & N
- Page 201 and 202: CONFIDENTIAL References Regulatory
- Page 203: Annex 1.8: Report from Imfeld (Univ
- Page 240:
Annex 2.2: Roberfroid, M.B., 1999;
- Page 244:
Annex 3.2: “Letter of no objectio
- Page 247 and 248:
1 Nutrition and Health Claims (CAC/
- Page 249 and 250:
3 Nutrition and Health Claims (CAC/
- Page 251 and 252:
5 Nutrition and Health Claims (CAC/
- Page 361:
Annex 3.2: “Letter of no objectio
- Page 364 and 365:
1 Nutrition and Health Claims (CAC/
- Page 366 and 367:
3 Nutrition and Health Claims (CAC/
- Page 368:
5 Nutrition and Health Claims (CAC/